1 / 23

Varicella Immunity and History of Infection

Varicella Immunity and History of Infection. Maryellen E. Gusic MD Assistant Professor of Pediatrics Penn State Children’s Hospital. Introduction. Immunization against varicella is recommended for susceptible, immunocompetant children over the age of 12 months.

polly
Télécharger la présentation

Varicella Immunity and History of Infection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Varicella Immunity and History of Infection Maryellen E. Gusic MD Assistant Professor of Pediatrics Penn State Children’s Hospital

  2. Introduction • Immunization against varicella is recommended for susceptible, immunocompetant children over the age of 12 months. • A reliable history of naturally occurring infection is considered to be evidence of immunity.

  3. Introduction continued • Infection rarely occurs without the development of characteristic skin lesions. • Parents are usually able to report a history of varicella infection in their child.

  4. Introduction continued • Varicella immunity requires • development of specific antibodies • stimulation of cell mediated immunity • Immune status of a child can be determined by measuring specific IgG immunoglobulin levels.

  5. Introduction continued • Varicella in infants • A modified specific antibody and cell mediated immune response has been described. • mild infection • effect of transplacentally acquired antibodies

  6. Introduction continued • Natural infection is thought to provide life long immunity. • Reinfections are observed in healthy children. • inaccurate diagnoses? • modified antibody and/or cell mediated immune response?

  7. Our Study • Hypotheses • Children infected with varicella early in life may have a modified immune response to infection and remain susceptible to reinfection. • Children whose infection was clinically mild, may not have developed protective antibody titers and thus also remain susceptible to reinfection.

  8. Objectives • To identify children with a history of natural infection whose illness occurred before 1 year of age • To identify children whose infection would be classified as mild or moderate by determining the number of skin lesions present during the illness

  9. Objectives continued • To determine if children with a history of natural infection before 1 year of age or with mild or moderate infection have protective antibody titers • To determine if further questions to describe the skin lesions present aid in supporting the “reliability” of the history of infection

  10. Methods • Children with a history of varicella infection identified by chart review and by parental questioning at clinic visits were included. • Children with a known immunodeficiency were excluded. • A varicella questionnaire was completed.

  11. Methods continued • Varicella questionnaire • patient’s current age • age at which varicella infection occurred • infection diagnosed by parent or health care professional • description of illness • vesicular, itchy, number of lesions

  12. Methods continued • Finger stick blood samples were obtained for those children whose infection occurred before one year of age or who had less than 250 lesions during their infection. • Serologic testing for anti-VZV IgG antibodies was performed by the National VZV Lab at the CDC.

  13. Methods continued • Serologic testing • ELISA assay for anti-VZV IgG antibodies • Results recorded as mean adjusted OD reading and by objective rating • 0.166 and above positive • Equivocal results retested at lower serum dilution

  14. Methods continued • Odds ratios were determined and a Chi square analysis was performed on the data. • Research was approved by the Institutional Review Board of the Hershey Medical Center and the Penn State University College of Medicine.

  15. Results • 32 patients were enrolled in the study • 11 children had <50 lesions • 21 children had moderate infection • 17 children were infected before 1 year of age • 5 children whose infection occurred before 1 year of age had mild infection • No child whose infection occurred before 1 year of age had >250 lesions

  16. Results continued • 30 patients underwent serologic testing • 4 patients had negative antibody titers • 6 patients had equivocal serologic results

  17. Conclusions • Children with a history of mild varicella infection should be evaluated to determine if they have protective antibody titers. • An immunocompetant child aged 12 months or older who has negative antibody titers should be immunized against varicella zoster virus.

  18. Conclusions continued • Determining if the rash associated with the infection was itchy may further support the reliability of the diagnosis. • Both parents and health care professionals may incorrectly identify an illness as varicella.

  19. Limitations of this Study • Power of study limited by the small number of patients enrolled • Results dependent upon parental reporting of age of infection, symptoms of disease • Negative serologic titers may be result of inaccurate diagnoses

  20. Implications for Future Research • Studies are needed to determine the factors that may interfere with the development of life long protective immunity to varicella infection. • Further studies identifying the clinical signs and symptoms that ensure the accuracy of diagnosing varicella have important public health considerations.

  21. A Special Thanks to... • Dr. Scott Schmid and the National VZV lab at the CDC • Beth Anne Nagy, MS II, Penn State College of Medicine • David Mauger, PhD, Department of Health Evaluation Sciences, Penn State College of Medicine

More Related